Hypobaric hypoxia causes body weight reduction in obese males, double-blinded, placebo-controlled study
B. Buchzik, M. Robinzonov, R. M. Huber, J. Behr, R. Kiefl, N. Robinzonov, M. Karasz, R. Fischer (Munich, Germany)
Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases
Session: Clinical problems in acute and chronic lung diseases
Session type: Thematic Poster Session
Number: 3650
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Buchzik, M. Robinzonov, R. M. Huber, J. Behr, R. Kiefl, N. Robinzonov, M. Karasz, R. Fischer (Munich, Germany). Hypobaric hypoxia causes body weight reduction in obese males, double-blinded, placebo-controlled study. Eur Respir J 2014; 44: Suppl. 58, 3650
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Dietary nitrate supplementation and exercise tolerance in chronic heart failure: A double-blind, randomized, placebo-controlled, crossover trial Source: International Congress 2016 – Clinical exercise physiology in health and disease Year: 2016
Effects of ghrelin on the dyspnea pattern in cachectic COPD: Exploratory analysis of a substudy of a multicenter, randomized, double-blind, placebo-controlled trial of ghrelin treatment Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013
Acute improvement of pulmonary hemodynamics does not alleviate Cheyne-Stokes respiration in chronic heart failure - a randomized, controlled, double-blind, crossover trial Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing Year: 2013
A double-blind, randomized, sham-controlled study of Targeted Lung Denervation in patients with moderate to severe COPD : AIRFLOW-2 One Year Outcomes Source: International Congress 2019 – Interventional pulmonology: a mixture of spices Year: 2019
Efficacy of the Plasma Cluster® device in mild to moderate asthmatic children: A randomized, double-blind, placebo-controlled, proof-of-concept trial Source: Annual Congress 2013 –Asthma treatment and management in children Year: 2013
A double-blind, randomized, sham-controlled study of Targeted Lung Denervation in patients with moderate to severe COPD Source: International Congress 2018 – Interventional pulmonology highlights in 2018: ELVR, TLD and BT Year: 2018
An auto-titrating intelligent oxygen therapy (iO2T) system in COPD patients: A randomised cross-over trial Source: International Congress 2015 – Tele-rehabilitation in chronic lung diseases Year: 2015
Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – A prospective, randomized, controlled trial Source: International Congress 2016 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2016
Supplemental dietary nitrate for COPD: A randomized, double-blind, placebo-controlled, crossover trial Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation Year: 2013
LATE-BREAKING ABSTRACT: The benefits of [italic]Nigella sativa[/italic] oil supplementation on asthma inflammation: A randomised, double-blind, placebo-controlled, phase II trial Source: International Congress 2016 – Novel strategies on COPD and asthma management Year: 2016
Efficacy and safety of isoproterenol continuous inhalation treatment for acute severe exacerbation of asthma in children; a randomized, double-blind controlled study Source: International Congress 2015 – Paediatric asthma and allergy: asthma management Year: 2015
Impact of whole body vibration training on balance and muscle power in patients with severe COPD – A randomized, controlled trial Source: International Congress 2016 – Best abstracts in exercise capacity and testing in chronic lung diseases Year: 2016
CPAP effects on leptin and visceral fat in patients with sleep apnea: Double-blind, randomized, controlled trial Source: Annual Congress 2011 - Physiology and cardiometabolic comorbidities in obstructive sleep apnoea Year: 2011
LATE-BREAKING ABSTRACT: COPD-associated severe pulmonary hypertension (COPDPH): results of a 16-weeks prospective multicenter, double-blind, placebo-controlled randomized clinical trial (RCT) [SPHERIC-1 (http://clinicaltrials.gov/ct2/show/NCT01441934)] investigating the effect of sildenafil citrate (Sld) on pulmonary vascular resistance (PVR) and PaO2. Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013
Effect of borago extract on moderate persistent asthma, a phase two randomized, double blind placebo-controlled clinical trial Source: International Congress 2016 – Asthma management Year: 2016
Levodropropizine effect on respiratory centre output, a randomized clinical trial Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016
A prospective, randomised, controlled trial of CPAP in adults with Down syndrome Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity Year: 2015
Visceral adiposity, TNFα, CRP and CPAP effect in patients with sleep apnea – A double-blind, randomized, placebo-controlled trial Source: Annual Congress 2010 - News from RCT (randomised controlled trials) and epidemiology in sleep apnoea Year: 2010
Effects of whole body vibration in Japanese patients with chronic obstructive pulmonary disease. A randomized controlled trial Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013
Inhaled mannitol for non-cystic fibrosis bronchiectasis - results of a 12 month, multi-centre, double-blind, controlled study Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013